Sumar Biotech LLP - pharma in Mehsana, Gujarat, India. FY 2026 financials & compliance.
LLPIN AAL-8744 Incorporated 30 January 2018 ROC Ahmedabad HQ Mehsana, Gujarat, India
Active Limited Liability Partnership pharma DPIIT Startup MSME · Medium
Revenue · FY 2023
₹58.12 Cr
Latest filing
Net profit · FY 2023
₹4.11 Cr
Net margin 7.1%
EBITDA · FY 2023
₹10.06 Cr
EBITDA margin 17.3%
Contribution obligation
₹50 Lakh
As per LLP agreement
Open charges
₹15 Cr
Secured borrowings
LLP age
8 yrs
Est. 2018
Employees · EPFO
88
Provident fund records
Designated partners
3
As per MCA filings

About Sumar Biotech LLP

Data last updated:

Sumar Biotech LLP is a limited liability partnership (LLP) based in Mehsana, Gujarat, India, recognised as a startup by DPIIT. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 January 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAL-8744. Its GSTIN is 24ADOFS9536L1ZA (Gujarat).

The LLP has a total obligation of contribution of ₹50 Lakh. It is led by designated partners including Jaimin Nitinkumar Patel and Tusharkumar Rameshbhai Patel.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No. 112 To 114 GIDC At: – Gozariya, Mehsana, Gujarat, India – 382825.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹58.12 Cr. For the same year it recorded a net profit of ₹4.11 Cr (net margin 7.1%) and EBITDA of ₹10.06 Cr (EBITDA margin 17.3%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.

The LLP has about 88 employees on its provident fund (EPFO) records.

As per MCA filings, the LLP has open charges of ₹15 Cr on record. Court records list 3 cases involving the LLP, including 3 filed against it; 1 case is pending.

Sumar Biotech LLP is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0001761).

Company details

LLPIN AAL-8744
Incorporation Date 30 January 2018
Total Obligation of Contribution ₹50 Lakh
ROC Ahmedabad
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Medium
Udyam Registration UDYAM-GJ-14-0001761

Recognitions & Rankings of Sumar Biotech

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-14-0001761

Contact details

Sumar Biotech LLP's registered office is in Mehsana, Gujarat. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. 112 To 114 GIDC At: – Gozariya, Mehsana, Gujarat, India – 382825
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Sumar Biotech LLP, buy the company report.

Comprehensive company report
Sumar Biotech LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Sumar Biotech LLP

FY 2025 filings available

Sumar Biotech LLP reported revenue of ₹58.12 Cr for FY 2023.

Revenue · FY 2023
₹58.12 Cr
Net profit · FY 2023
₹4.11 Cr margin 7.1%
EBITDA · FY 2023
₹10.06 Cr margin 17.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 81%
EBITDA CAGR growth
3 years · compounded
▲ 211%

Revenue has grown at a compounded annual rate (CAGR) of 81% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income₹58.12 Cr
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax₹4.11 Cr
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin7.1%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Sumar Biotech LLP, buy the company report.

Designated partners of Sumar Biotech LLP

Sumar Biotech has 3 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Jaimin Nitinkumar PatelDesignated Partner02 Dec 20232 Years 11 MonthsCurrent
Tusharkumar Rameshbhai PatelDesignated Partner30 Jan 20188 Years 9 MonthsCurrent
Sunny Nitinkumar PatelDesignated Partner30 Jan 20188 Years 9 MonthsCurrent

Charges & borrowings

Open charges
₹15 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹15.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Mar 2020100329528Hdfc Bank Limited₹15 CrOpen

To see the full charge records of Sumar Biotech LLP, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sumar Biotech LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sumar Biotech LLP has a workforce of 88 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
88
Active EPFO establishments
1
Employee growth
125.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2788
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Sumar Biotech LLP, buy the company report.

GST

Sumar Biotech has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24ADOFS9536L1ZAGujaratActive27 Mar 2018

To see the full GST registrations and return filing status of Sumar Biotech LLP, buy the company report.

Recent activity

Sumar Biotech LLP has 5 designated partner changes on record since 2018: 3 appointments and 2 cessations. The latest: Jaimin Nitinkumar Patel was appointed as Designated Partner on 02 Dec 2023.

AGM
Sumar Biotech Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Sumar Biotech Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Jaimin Nitinkumar Patel was appointed as Designated Partner.
Ceased
Jaimin Nitinkumar Patel ceased to be Partner.
Charges
A charge with Hdfc Bank Limited of Rs. 1,500.00 Lakh registered on 12 Mar 2020 with Charge ID 100329528 was modified on 01 Sep 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,500.00 Lakh with Charge ID 100329528 was registered on 12 Mar 2020.
Ceased
Nirav Nalinkumar Vyas ceased to be Designated Partner.
Appointed
Sunny Nitinkumar Patel was appointed as Designated Partner.
Appointed
Tusharkumar Rameshbhai Patel was appointed as Designated Partner.
Incorporation
30 Jan 2018
Sumar Biotech Llp was registered on 30 Jan 2018 with Roc Ahmedabad & aged 8 years 9 months as per MCA records.

Frequently asked questions

Sumar Biotech is an active limited liability partnership based in Mehsana, Gujarat, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 30 January 2018 (8+ years old) and is registered under LLPIN AAL-8744.

Sumar Biotech has 3 current designated partners:

The latest financial statements of Sumar Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Sumar Biotech is 24ADOFS9536L1ZA, registered in Gujarat.

The LLPIN (Limited Liability Partnership Identification Number) of Sumar Biotech is AAL-8744. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Sumar Biotech has 3 court cases on record: 3 filed against it. 1 is pending.

Sumar Biotech was incorporated on 30 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Jaimin Nitinkumar Patel was appointed as Designated Partner on 02 Dec 2023. Jaimin Nitinkumar Patel ceased to be Partner on 01 Dec 2023. Nirav Nalinkumar Vyas ceased to be Designated Partner on 16 Sep 2019. Sumar Biotech has 5 designated partner changes on record in total.

Yes, Sumar Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Sumar Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-14-0001761).